SAN ANTONIO, March 1, 2017 /PRNewswire/ -- Royal Philips
(NYSE: PHG, AEX: PHIA) today announced upcoming additions to its
portfolio of pathology solutions as part of its presence at the
2017 United States and Canadian Academy of Pathology (USCAP) Annual
Meeting. At the Philips booth (#202), USCAP attendees will
experience a broadened portfolio of computational pathology and
digital pathology solutions and services that extend collaboration
and efficiencies with the aim of supporting improved patient
care.
Pathology plays a critical role in the detection and diagnosis
of a wide variety of diseases, including cancer. Increasing cancer
incidence, an aging population and efforts to improve patient
outcomes have put cancer diagnostics and pathology services under
considerable pressure. Digitization of the tissue slide that the
pathologist normally views using a microscope could help increase
operational efficiencies, while advanced image recognition and
genomics information technology could further support the
pathologist in automation and potentially help increase accuracy in
pathology.
As part of this year's USCAP, Philips will unveil these new
technologies that showcase our expansion plans for open pathology
solutions, and participate in industry discussions on the
transition to digital.
Global collaboration and expertise sharing
Philips
IntelliSite Collaboration Suite is a new software as a service
being developed on Philips HealthSuite digital platform that will
connect pathologists worldwide. This case sharing platform aims to
allow pathologists to have easy access to expertise and
consultation services to speed turnaround times and enable cost
savings for consultation. Users will be able to share cases with
specific specialists or set up new connections. With Collaboration
Suite, there is the opportunity to open new business models for
both pathologists and pathology laboratories alike, and can extend
their consultation services globally. The Collaboration Suite
global roll-out is expected in the second half of 2017.
Computational pathology and smart image analytics
As
an early innovator in computational pathology, Philips wants to
empower pathologists to support improved patient care. The suite of
computational pathology solutions include quantitative support to
the pathologist, as well as guidance in tissue extraction for
molecular diagnostics.
Philips Digital Pathology Solutions portfolio is being expanded
to support computational pathology offerings from Philips as well
as partners. We aim to offer computational pathology solutions
along three strategic directions. First, clinically validated image
analysis applications that aim to assist the pathologist in routine
case review, which could help to standardize and facilitate first
time right decisions. In partnership with Visiopharm, we will offer
applications for semi-quantification of breast IHC
markers1.
Second, Philips' research application TissueMark2
that helps in automatic identification of tumor region and
subsequent quantification for macro dissection. Third, Philips'
research application Xplore2 that enables image and
study data management, and biomarker discovery with additional
tools that help streamline research and biomarker discovery.
Open platform for building digital pathology
ecosystem
Philips IntelliSite Pathology
Solution3 will add new capabilities in its open research
platform allowing support of additional image file formats to its
image management system, including DICOM. This could potentially
offer users the ability to leverage prior investments in scanners
and extend their utility as they grow their digital pathology
networks. We are committed to work with partners to develop state
of the art computational pathology applications via our open
platform.
Educational session
Philips will host a seminar &
luncheon "Digital pathology moving from pilot to practice" on
March 6th 12:00 –
1:00 pm CT in the Bowie Room at the
San Antonio Grand Hyatt Hotel. The event will include discussions
featuring Philips Digital Pathology Solutions' Esther Abels, guest speakers Andrew H. Beck, MD, PhD from Beth Israel
Deaconess Medical Center and Anil Parwani, MD, PHD, MBA, professor
at The Ohio State University, and
Director of Pathology Informatics and Digital Pathology Shared
Resource at The James Cancer Hospital. The event is open to all
USCAP attendees.
For more information on Philips' presence at the 2017 United
States and Canadian Academy of Pathology Annual Meeting, visit
www.philips.com/digitalpathology and follow @Philips_Path
for #USCAP17 updates throughout the event.
1) Visiopharm is the legal manufacturer of
the breast IHC applications (HER2, ER, PR, Ki67). The applications
are CE-IVD for Europe and Research
Use Only for United States and
Rest of the world.2) TissueMark and Xplore is a research
application. PathXL is legal manufacturer. 3) Philips
IntelliSite Pathology Solution is CE-IVD marked. In the United States, the Philips IntelliSite
Pathology Solution pending review of a request for de novo
classification.
For further information, please contact:
Hans Driessen
Philips Digital Pathology Solutions
Tel: +31 6 10610417
E-mail: hans.driessen@philips.com
About Royal
Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a
leading health technology company focused on improving people's
health and enabling better outcomes across the health continuum
from healthy living and prevention, to diagnosis, treatment and
home care. Philips leverages advanced technology and deep clinical
and consumer insights to deliver integrated solutions.
Headquartered in the Netherlands,
the company is a leader in diagnostic imaging, image-guided
therapy, patient monitoring and health informatics, as well as in
consumer health and home care. Philips' health technology portfolio
generated 2016 sales of EUR 17.4
billion and employs approximately 71,000 employees with
sales and services in more than 100 countries. News about Philips
can be found at www.philips.com/newscenter.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/philips-introduces-new-digital-solutions-and-services-to-advance-pathology-at-the-2017-uscap-annual-meeting-300415632.html
SOURCE Royal Philips